TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GRCL

Gracell Biotechnologies Inc.

Healthcare · Biotechnology

485.20$ -2.8% vs. previous close Closing price · As of: Aug 13, 2026

Investor relations

Report Dates

Investor relations overview for Gracell Biotechnologies Inc. (GRCL): report dates, earnings surprises, earnings call transcripts and the latest headlines.

Next report –
Last report 11/13/2023
Earnings surprise by quarter (%)
Q4 20 · 38.5 % 20 Q1 21 · -19.1 % 21 Q2 21 · -66.7 % 21 Q3 21 · -150.0 % 21 Q4 21 · 9.1 % 21 Q1 22 · -66.7 % 22 Q2 22 · -328.6 % 22 Q3 22 · -169.2 % 22 Q4 22 · -76.5 % 22 Q1 23 · 10.3 % 23 Q2 23 · 25.0 % 23 Q3 23 · 50.0 % 23

EPS estimate beaten

Full history 5 of 13 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?